Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 186 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1851 ? Unresectable liver cancer Immunotherapy
Oita Medical University Japan 3/2003
Treatment Details: Patients: This Phase I study involved 10 patients with unresectable liver cancer. Eight had hepatocellular carcinoma and two had cholangiocellular carcinoma. Treatment: The treatment co
 
1852 ? Liver cancer and other cancers Alternative
Kobe Pharmaceutical University Japan 6/2002
Treatment Details: Patients: This non-randomized trial involved a total of 36 patients comprised of: 12 liver cancer patients, 16 breast cancer patients, and 8 lung cancer patients. Treatment: The trea
 
1853 ? Advanced NSCLC 3 Biologic therapy
Tohoku University Japan 7/2006
Treatment Details: Patients: This Phase II trial involved a total of 75 patients with advanced non-small-cell lung cancer. There were 30 men and 45 women. Subtypes included adenocarcinoma (64 patients) and n
 
1854 ? rectal cancer 4 Chemotherapy
Radiation
Duke University Medical Center United States 2/2006
Treatment Details: Patients: This Phase I study involved 6 patients (4 men, 2 women, median age 71) with rectal cancer and 10 patients (6 men, 4 women, median age 65) with pancreatic cancer. Treatment: T
 
1855 ? advanced or recurrent breast cancer 4 Chemotherapy
Saitama Medical School Hospital Japan 1/2006
Treatment Details: Patients: This phase II study involved 23 women (median age 57) with advanced or recurrent breast cancer. Treatment: Treatment consisted of chemotherapy - capecitabine (Xeloda). Tox
 
1856 ? hepatocellular carcinoma (intermediate-advanced) Biologic therapy
Civil Hospital of Vimercate Italy 6/2005
Treatment Details: Patients: 179 patients with intermediate or advanced stage liver cancer started this study. These patients (123 men and 56 women; mean age 64.9 years) were not eligible for other therapies
 
1857 ? Stage III/IV Ovarian cancer 4 Chemotherapy
Laikon General Hospital Greece 11/2005
Treatment Details: Patients: This phase II study involved 41 patients with FIGO III/IV ovarian cancer. The median age was 60 years. 19 patients received optimal debulking surgury and 17 patients received sub
 
1858 ? Metastatic rcc 4 Biologic therapy
Immunotherapy
The Methodist Hospital Research Institute United States 2/2006
Treatment Details: Patients: The phase I/II study involved a total of 52 patients with metastatic renal cell carcinoma. Treatment: The treatment consisted of a combination of biological therapy (thalidomi
 
1859 ? Recurrent Ovarian cancer 4 Chemotherapy
Dana Farber/Partners Cancer Care Program United States 4/2006
Treatment Details: Patients: This phase II trial involved 74 patients with epithelial ovarian cancer. Patients were separated into two groups - 58 women with platinum-resistant disease and 16 with platinum-s
 
1860 ? Advanced NSCLC 3 Biologic therapy
Okayama University Hospital Japan 4/2006
Treatment Details: Patients: This Phase I study involved 15 patients (14 men, 1 woman, median age 58 years) with advanced non-small-cell lung cancer. The patients also carried genetic mutations for the tumor
 
Page 186 of 187  | Previous Page  | Next Page